Delivery Order SPE2DB24D1021-SPE2DB25FEUMZ
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,786.17 firm fixed-price delivery order is for the supply of 120 tablets of Alfuzosin HCL ER 10 mg, a medication used to treat the symptoms of an enlarged prostate. The contract has an ultimate completion date of July 12, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,790.16, is for the delivery of Alfuzosin HCL ER 10 mg tablets, a medication used to treat symptoms of an enlarged prostate. The contract has a firm fixed price and runs through March 13, 2025. It is not designated as a set-aside contract. AmerisourceBergen also holds a...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 90-count packages of Alfuzosin HCL ER 10 mg tablets, a medication used to treat enlarged prostate, at a ceiling value of $20,091.92. This contract was awarded as a delivery order, with a firm fixed price, and does not have a set-aside designation, indicating open...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $9,984.53, is for the delivery of 120 tablets of Alfuzosin HCl ER 10 mg, a medication used to treat benign prostatic hyperplasia. This is a firm fixed-price delivery order contract with an ultimate completion date of November 18, 2024. The contract is not designated with a set-aside requirement, indicating open...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and federal contractor. The $2,086.06 firm-fixed-price contract is for the supply of 120 tablets of Alfuzosin HCL ER 10 mg, a medication used to treat benign prostatic hyperplasia. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999...
- This is a federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $8,518.82, is a delivery order from the Defense Logistics Agency (DLA) for the supply of 120 tablets of Alfuzosin HCL ER 10 mg, a medication used to treat symptoms of an enlarged prostate. The contract has an ultimate completion date of June 21, 2024. Amerisourcebergen holds a significant...
- This federal contract award, valued at $17,416.03, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Alfuzosin HCL ER 10 mg tablets, a medication primarily used to treat symptoms of an enlarged prostate. The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 120 tablets of Alfuzosin Hydrochloride Extended Release 10 mg, a medication used to treat an enlarged prostate. The contract has a firm fixed price of $2,107.38 and a completion date of May 28, 2025. This delivery order is not set aside and was awarded on May 27, 2025....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,663.29 firm fixed price delivery order is for 90 tablets of Alfuzosin HCl ER 10 mg, a medication used to treat benign prostatic hyperplasia. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,116.97 firm fixed-price delivery order is for the supply of Alfuzosin HCl ER 10 mg tablets, a medication used to treat benign prostatic hyperplasia. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FEUMZDelivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,626.79, is for the delivery of 120 tablets of Alfuzosin HCl ER 10 mg, a medication used to treat the symptoms of an enlarged prostate. The contract has a completion date of March 6, 2025 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 3/5/25 |